Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Fibroblast growth factor receptors (FGFRs) 1-3 exhibit alternative splicing in the IgIII loop, producing b- and c-variants.
• These variants possess distinct ligand-binding spectra and biological functions.
• FGFR splice variants play critical roles in embryonic development, tissue homeostasis, and cancer progression.

Purpose of the Study:

• To summarize the expression patterns of FGFR splice variants in various tumor types.
• To outline methodologies for analyzing splicing events during tumorigenesis.
• To explore the role of FGFR 1-3 IIIb and IIIc in malignancy pathophysiology.

Main Methods:

• Review of existing literature on FGFR alternative splicing.
• Analysis of tissue-specific expression patterns of FGFR splice variants in tumors.
• Discussion of recent advancements in analyzing splicing regulation and RNA-protein interactions.

Main Results:

• Alternative splicing of FGFRs generates functionally distinct receptor variants.
• Aberrant FGFR2 splicing is implicated in epithelial-mesenchymal transition and tumor metastasis.
• Regulatory factors influencing splice choice involve exogenous signaling and RNA-protein interactions.

Conclusions:

• FGFR splice variants are key regulators in normal development and disease, particularly cancer.
• Understanding FGFR splicing alterations offers insights into tumor progression mechanisms.
• Further analysis and application of FGFR splicing knowledge hold therapeutic potential for malignancies.